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Illuminating cardiac development: Advances in imaging add new
dimensions to the utility of zebrafish genetics
Jeffrey J. Schoenebeck and Deborah Yelon
Developmental Genetics Program and Department of Cell Biology Skirball Institute of Biomolecular
Medicine New York University School of Medicine 540 First Avenue New York, NY 10016 USA
Abstract
The use of the zebrafish as a model organism for the analysis of cardiac development is no longer
proof-of-principle science. Over the last decade, the identification of a variety of zebrafish mutations
and the subsequent cloning of mutated genes have revealed many critical regulators of cardiogenesis.
More recently, increasingly sophisticated techniques for phenotypic characterization have facilitated
analysis of the specific mechanisms by which key genes drive cardiac specification, morphogenesis,
and function. Future enrichment of the arsenal of experimental strategies available for zebrafish
should continue the yield of high returns from such a small source.
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1. Benefits of the zebrafish as a model organism: making the most of a little
heart
The road to creating a fully functional heart is complex. Heart formation begins with the
specification of appropriate numbers and types of cardiac cells. Next, these cells coordinate
their migration and interaction in order to assemble a simple, yet functional, heart tube. Further
morphogenesis transforms the heart tube into morphologically and functionally discrete
cardiac chambers. Even minor perturbations of cardiac specification or morphogenesis can
have catastrophic consequences for cardiac function. To understand the etiology of congenital
heart defects, it is essential to dissect the individual processes that combine to create the
intricacy of the mature heart.
An ideal model organism for the study of heart formation would allow high-resolution
inspection of cellular activities in conjunction with genetic analysis of regulatory influences.
The zebrafish fulfills these criteria beautifully, and it has therefore been steadily gaining in
popularity as a valuable model of cardiogenesis [1,2]. A large part of its appeal derives from
the transparency of the zebrafish embryo, which permits detailed examination of heart size,
shape, and function. Additionally, the zebrafish presents excellent opportunities for conducting
forward genetic screens, primarily due to its small size, fecundity, and brief generation time
[3]. Screening for cardiac phenotypes is particularly convenient, since the zebrafish embryo
does not require a functional cardiovascular system for survival during embryogenesis [4]. The
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first two large-scale zebrafish screens, completed in 1996, clearly illustrated the effectiveness
of zebrafish genetics [5,6]. Together, these screens found more than 1600 mutations affecting
specific aspects of zebrafish embryogenesis; more than 100 of these mutations, representing
66 loci, disrupt cardiac form or function [7,8].
The availability of a large collection of zebrafish mutations provided investigators with a
plethora of opportunities to identify new genes with critical roles in cardiogenesis. Indeed,
subsequent studies of these mutations, together with mutations found in independent screens
(e.g. [9,10]), have led to the cloning of more than 35 of the mutated genes, many of which are
discussed below. This catalog of genes involved in cardiogenesis is impressive, yet it represents
only the first step toward understanding how these genes function. Take, for example, a mutant
exhibiting a small heart phenotype that is caused by a lesion in a gene encoding a transcription
factor. An initial interpretation of these data would implicate this factor in the regulation of
heart size, but deeper analysis would be required to reveal its precise role. Does this
transcription factor promote the accumulation of cardiomyocytes by inducing cardiac
specification or controlling proliferation? Does it influence heart size by regulating the size of
individual cardiomyocytes? Does it control the three-dimensional organization of cells within
the cardiac chambers? To distinguish between such hypothetical models of gene function, it is
essential to have on hand the appropriate techniques for detailed characterization of mutant
phenotypes.
In the past several years, a number of zebrafish laboratories have prevailed in moving beyond
the level of gene discovery: in addition to using zebrafish genetics and genomics to rapidly
clone mutated genes, they have taken advantage of the optical attributes of the embryo by
developing experimental strategies and techniques suitable for high-resolution phenotypic
analysis. In this review, we will highlight three categories of imaging-based techniques that
have been particularly helpful in illuminating specific aspects of zebrafish cardiogenesis: fate
mapping strategies for the analysis of cardiac specification, visualization of the dynamic
cytoarchitecture that underlies cardiac morphogenesis, and high-speed imaging for the
investigation of cardiac function. Far from being a comprehensive review, the studies
recognized here serve a sample and a prelude of the potential for studying cardiac development
in zebrafish.
2. Fate mapping: a retrospective approach to identifying progenitor potential
Though morphologically simpler than its mammalian counterpart, the physical components of
the zebrafish heart are fundamentally similar [1]. The zebrafish heart has two major contractile
chambers, a ventricle and an atrium. Each chamber is composed of an outer layer of
myocardium and an inner layer of endocardium. During remodeling of the primitive heart tube,
the ventricular myocardial wall thickens, supporting extensive trabeculation that is largely
absent in the atrium [11]. In addition to displaying unique morphologies, the cardiac chambers
are also molecularly distinct; for instance, they express chamber-specific myosin heavy chain
genes, vmhc in the ventricle and amhc in the atrium [12,13]. The formation of cardiac chambers
has its roots in the specification and patterning of cardiac progenitors (CPs) [14]. Prior to their
differentiation, CPs reside in bilateral heart fields where they receive inductive signals that
promote their determination as well as their subdivision into ventricular and atrial populations.
In addition to inductive signaling, the heart fields are also subject to inhibitory signaling that
limits their effective size. Thus, cardiac specification requires a combination of signals and
downstream effectors to insure the production of an appropriate quantity and variety of
cardiomyocytes.
A number of zebrafish mutations have potent effects on cardiomyocyte production, and studies
of these mutations have implicated several signaling pathways and downstream transcription
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factors in cardiac specification. In acerebellar (fgf8) and swirl (bmp2b) mutants, the number
of cardiomyocytes is severely decreased; this deficiency is preceded by gene expression
defects, including reduced expression of the transcription factor gene nkx2.5 [15,16]. A similar
phenotype is observed in one-eyed pinhead mutants, which lack an essential coreceptor in the
Nodal signaling pathway [16]. Furthermore, in acerebellar and one-eyed pinhead mutants, the
deficiency of ventricular tissue is more severe than the deficiency of atrial tissue, suggesting
roles for Fgf8 and Nodals in chamber fate assignment [15,16]. Mutations in the transcription
factor gene faust (gata5) also result in reduced expression of nkx2.5 and severe deficiencies in
cardiomyocyte production, especially for ventricular cardiomyocytes [17]. Epistasis
experiments suggest that Gata5 functions downstream of Bmp2b and Nodal signaling [16].
Mutants lacking the transcription factor gene hands off (hand2) also produce too few
cardiomyocytes but do not exhibit defects in nkx2.5 or gata5 expression, suggesting a
downstream or parallel role for Hand2 in promoting cardiogenesis [18]. In contrast to mutations
causing cardiomyocyte deficiencies, mutation of neckless (retinaldehyde dehydrogenase 2)
causes a striking cardiomyocyte surplus [19]. Retinaldehyde dehydrogenase 2 controls the rate-
limiting step of retinoic acid (RA) synthesis; thus, this mutant phenotype suggests that RA
signaling plays an important role in restricting cardiomyocyte production.
The analysis of zebrafish mutations affecting cardiomyocyte formation suggests strong
candidates for signaling pathways that induce or repress cardiac specification. However, there
are other possible explanations for the abnormal numbers of cardiomyocytes observed in
mutant embryos. For example, perhaps acerebellar mutants lack myocardium because Fgf8 is
required for cardiomyocyte proliferation and viability, or perhaps the phenotype of neckless
mutants could be explained by excess cardiomyocyte proliferation in the absence of RA
signaling. To distinguish between various mechanisms influencing cardiomyocyte production,
it is important to have a baseline understanding of where CPs originate in the early embryo
and how each CP contributes to the total number of cardiomyocytes; that is, it is critical to
define the fate map of CPs in the wild-type embryo.
Through refinement of an established fate mapping protocol [20], Keegan et al. have generated
a high-resolution fate map of CPs within the late blastula, thereby providing a valuable
reference for the analysis of pathways affecting cardiac specification [21]. This experimental
strategy involves labeling individual blastomeres using a noninvasive optical method: laser-
mediated activation of a caged fluorescein-dextran conjugate (Figure 1A,B). This lineage tracer
can be distributed throughout the embryo via injection at the one-cell stage; cells are later
selected for photoactivation simply by focusing the laser on any visible targets. Tracking the
progeny of labeled cells indicates their paths through the embryo and their contributions to
differentiated tissues (Figure 1C–E, H–J). By correlating cardiac contributions with initial
blastomere positions, the wild-type fate map reveals the location of CPs within the lateral
marginal zone (LMZ) of the late blastula, the density of CPs among the cells in this
multipotential region, and the productivity of a typical CP in terms of the number of
cardiomyocytes generated [21]. Additionally, the fate map demonstrates a distinct spatial
organization of ventricular and atrial CPs prior to gastrulation: ventricular CPs tend to be
located closer to the margin and more dorsal than are atrial CPs (Figure 1F). Although there
is overlap between the areas containing ventricular CPs and atrial CPs (Figure 1F), individual
blastomeres at this stage do not give rise to both ventricular and atrial cardiomyocytes [21], in
accordance with an early separation of ventricular and atrial lineages [22]. Following
gastrulation, CPs coalesce to form a portion of the anterior lateral plate mesoderm (ALPM)
(Figure 1G,H). The relative organization of ventricular and atrial CPs persists within the
ALPM, with ventricular CPs occupying a more medial portion of the ALPM than do ACPs,
as demonstrated by a recent fate map of the ALPM during early somitogenesis stages (J.J.S.
and D.Y., unpublished data) and by the regionalized expression patterns of vmhc and amhc
once cardiac differentiation begins (Figure 1B,C,G,H) [12,13].
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The wild-type fate map provides valuable insight into the organization of CPs at stages before
they are recognizable with molecular markers; the strength of fate mapping as an experimental
strategy becomes even more apparent when it is applied to the analysis of embryos exhibiting
abnormal cardiomyocyte populations. For example, as mentioned above, one-eyed pinhead
mutants display a more striking deficiency of ventricular cardiomyocytes than of atrial
cardiomyocytes [16], but this observation alone does not demonstrate whether Nodal signaling
promotes ventricular fate assignment, differentiation, growth, or survival. The relative
orientation of ventricular and atrial CPs in the late blastula (Figure 1F) raises the possibility
that chamber fate assignment could be influenced by differential exposure to Nodal ligands
that are secreted from the embryonic margin. To test this hypothesis, alterations to the CP fate
map were examined in embryos with reduced levels of Nodal signaling [21]. In contrast to the
wild-type fate map, the distribution of CPs shifted toward the margin when Nodal signaling
was reduced. In wild-type embryos, the blastomeres closest to the margin never become atrial
CPs; in embryos with reduced Nodal signaling, both ACPs and VCPs were found adjacent to
the margin. This fate transformation indicates that Nodal signaling promotes the assignment
of ventricular fate in CPs derived from the most marginal blastomeres.
In addition to detecting alterations in patterning of the heart fields, fate mapping can be a
powerful strategy for monitoring the number of CPs and their production of cardiomyocytes.
For instance, the observation that reduction of RA signaling results in an increased number of
cardiomyocytes suggested that RA signaling could repress the formation of CPs; alternatively,
RA could restrict the number of cardiomyocytes produced by individual CPs. To distinguish
between these potential roles of RA, Keegan et al. constructed a CP fate map in embryos treated
with a RA receptor antagonist [19]. This analysis revealed that a loss of RA signaling causes
a fate transformation that increases the number of CPs within the LMZ, presumably at the
expense of other mesendodermal cell types. Although there were more CPs in antagonist-
treated embryos, the typical CP appeared to produce a normal number of cardiomyocytes; the
average cardiac contribution per CP was comparable (~4–5 cardiomyocytes) to that observed
in the wild-type fate map. Thus, RA signaling plays a critical role in restricting the specification
of CP identity.
It is clear that several pathways act to induce, limit, and organize cardiac specification within
the zebrafish heart fields. Fate mapping of CPs can yield significant insights by providing both
visible and quantifiable data for the assessment of CP density, productivity, and organization.
As investigators continue to uncover genes that affect the production of ventricular and atrial
myocardium, high-resolution fate mapping in the late blastula (Figure 1A,E) and also at
subsequent stages (Figure 1B,G) will remain an indispensable tool for defining the impact of
these genes on cardiac specification. Ultimately, extensions of these studies should reveal the
full landscape of signals responsible for creating the terrain depicted by the CP fate map.
3. Defining cardiac cytoarchitecture: subcellular mechanics of
morphogenesis
Once cardiac specification is complete, substantial morphogenetic changes are necessary to
create the three-dimensional form of the functional heart [23]. First, as myocardial
differentiation progresses, the bilateral populations of cardiomyocytes move medially,
eventually merging at the embryonic midline. Through a process called cardiac fusion, they
form a ring of cells, referred to as the cardiac cone (Figure 1C,H), that encircles the endocardial
precursors. Next, the cardiac cone extends into a linear tube: the cone’s axis gradually lengthens
and shifts from a dorsal-ventral plane to an anterior-posterior plane (Figure 1C,D,H,I). Once
extension is complete, the heart tube is a muscular cylinder lined with endocardium, and the
inner and outer circumferences of the cone have become the arterial and venous apertures of
the tube (Figure 1D,I). Next, localized bulges emerge from the walls of the heart tube: this
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process, called ballooning, creates the characteristic curvatures of the ventricle and the atrium
(Figure 1E,J). Chambers are further demarcated by the distinctive constriction of the
atrioventricular (AV) canal; morphogenetic changes also occur inside this portion of the heart,
where endocardial cushions (ECs) form and are then remodeled into AV valve leaflets [24].
Altogether, cardiac morphogenesis is a dynamic and multifaceted process that must be
carefully regulated to insure proper cardiac structure.
Many zebrafish mutations disrupt cardiac morphology, and analysis of these mutants has
indicated several important regulators of discrete morphogenetic processes. In the most
extreme of these mutant phenotypes, the bilateral populations of cardiomyocytes never travel
to the midline, resulting in two separate hearts forming in lateral positions, a condition known
as cardia bifida [23]. Analysis of cardia bifida mutants has revealed key requirements for
myocardial migration. Mutations in the transcription factor genes casanova (sox32), bonnie
and clyde, and faust (gata5) and the Nodal coreceptor gene one-eyed pinhead all disrupt
endoderm specification and secondarily cause cardia bifida, suggesting that the endoderm
provides an important signal or substrate utilized by migrating cardiomyocytes [17,25–27].
The molecular mechanisms of endodermal-myocardial interactions remain mysterious,
although it is intriguing to consider a potential role for sphingolipid signaling, since the
sphingosine-1-phosphate receptor gene miles apart (edg5) plays a cell non-autonomous role
in promoting myocardial migration [28]. In addition to putative interactions with the endoderm,
migrating cardiomyocytes require interactions with components of the extracellular matrix,
particularly Fibronectin, as demonstrated by the cardia bifida phenotype of natter
(fibronectin) mutants [29].
Another class of zebrafish mutations permit myocardial migration to the midline but then affect
the morphology of the heart tube or cardiac chambers. Mutations in the genes heart and soul
(prcki), snakehead (atp1a1a.1), and nagie oko (mpp5) hinder heart tube extension: mutant
hearts resemble arrested cardiac cones or stunted heart tubes [12,30–34]. The PRKCi, Atp1a1a.
1, and Mpp5 proteins are all known to exhibit apicobasally polarized localization within
epithelial cells, suggesting the importance of cell polarity to the process of tube extension.
Mutations in the heart of glass (heg), santa (krit1), and valentine (ccm2) genes do not seem to
influence the shape of the heart tube, but they do cause severe distortion of chamber shape: the
mutant hearts have thin-walled, extremely dilated chambers [35,36]. All three of these genes
are expressed in endothelial cells, with heg clearly being expressed in the endocardium,
suggesting that endocardial-myocardial signaling plays a key role in regulating chamber wall
thickening. Epigenetic influences, such as the biomechanical forces created by blood flow, also
contribute to the formation of chamber shape. The zebrafish locus weak atrium encodes an
atrium-specific myosin heavy chain (amhc) that is required for atrial contractility [13]. In
addition to atrial defects and the consequent reduction in blood flow, weak atrium mutants also
display ventricular defects: the mutant ventricle acquires an unusually small shape without
characteristic chamber curvatures. Since amhc is expressed only in the atrium [13], this
ventricular phenotype represents a secondary consequence of atrial dysfunction, presumably
reflecting an impact of normal hemodynamics on chamber ballooning.
AV valve morphogenesis, like chamber morphogenesis, involves interplay between multiple
signals, including those generated by biomechanical forces. Several zebrafish mutations
interfere with the formation of ECs in the AV canal. For example, jekyll (udp-glucose
dehydrogenase) mutants fail to form ECs [37]. UDP-glucose dehydrogenase (Ugdh) produces
substrates used in the modification of extracellular matrix proteins that are known to facilitate
Wnt and Fgf signaling [38]. Perhaps Ugdh is important for the control of Wnt signaling during
EC formation: constitutive activation of Wnt signaling via mutation of the tumor suppressor
gene apc leads to excessive EC formation beyond the boundaries of the AV canal, and
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overexpression of apc inhibits EC formation [39]. Other studies employing pharmacological
inhibitors have suggested that Calcineurin/NFAT signaling promotes EC formation, while
Notch signaling inhibits EC formation [24,40]. Additionally, a number of lines of evidence
demonstrate that cardiac function plays a key role in the induction of ECs. Mutation of genes
that are important for cardiac contractility, including the cardiac actin gene cardiofunk
(actc1) and the cardiac troponin T gene silent heart (tnnt2), prevents EC formation, suggesting
that shear stress, produced by blood flow, or a stretch response, produced by contraction, could
be required to initiate valve development [24,41]. The notion of shear stress influencing valve
morphogenesis has also been suggested by Hove et al., who demonstrated that implanting
beads to obstruct blood flow at either the inflow or outflow end of the heart can inhibit EC
formation [42].
Altogether, studies of zebrafish mutations affecting cardiac morphogenesis indicate the vast
complexity of its regulation. To reveal the precise way that each pathway regulates a particular
morphogenetic process, it is essential to understand the effects that specific genes exert on the
dynamic changes to cardiac cytoarchitecture that underlie morphogenesis. How do the shapes
and sizes of individual cells dictate the dimensions of the entire organ? How do cell-cell
interactions contribute to morphological rearrangements? How do individual cell movements
establish larger patterns of tissue movement? The optical accessibility of the zebrafish provides
unparalleled opportunities for resolving the mechanisms of morphogenesis on a cellular and
subcellular level. Visualization of myocardial and endocardial cells has been greatly enhanced
by transgenes that express gfp in cardiomyocytes (e.g. Tg(cmlc2:egfp))[43] or endothelial cells
(e.g. Tg(flk1:egfp)) [24]. In concert with other molecular markers, these transgenes have been
instrumental in revealing how key regulatory genes effect changes in cellular polarity,
interactions, and morphology that, in turn, control specific steps of morphogenesis.
Any morphogenetic rearrangement of embryonic tissues is likely to begin with changes in the
cytoarchitecture of individual cells. For example, Trinh and Stainier have demonstrated that
migrating cardiomyocytes begin to form a polarized epithelium as they approach the embryonic
midline [29]. By examining the localization of markers of apicobasal polarity in embryos
expressing Tg(cmlc2:egfp) (Figure 2), they determined the dynamics of polarity acquisition in
differentiating cardiomyocytes. Intriguingly, mutations that disrupt apicobasal polarity, such
as natter and hands off, also inhibit myocardial migration; these data reveal previously
unappreciated roles of Fibronectin and Hand2 in the establishment of apicobasal polarity and
suggest that formation of a polarized epithelium is a requirement for the coordination of
myocardial migration [29,44]. Myocardial epithelial polarity also seems to be integral to the
process of heart tube extension. Both PRKCi and Mpp5 are components of apically localized
protein complexes, and analysis of prkci and mpp5 mutants demonstrates that both genes are
required cell-autonomously to insure the polarity and integrity of the myocardial epithelium
[34]. As Atp1a1a.1 is basolaterally localized in chick cardiomyocytes [45], it is interesting to
speculate that its function during heart tube extension could also be related to myocardial
apicobasal polarity [32]. Together, these data point to the importance of organization and
coherence of the myocardium during the formation of the cardiac cone and its transformation
into the heart tube.
Detailed examination of cytoarchitecture has also shed light on the mechanisms regulating AV
valve formation. Using Tg(flk1:egfp) and Tg(tie2:egfp) to visualize endocardium, Beis et al.
determined that EC formation is preceded by striking changes in cell shapes and protein
localization within the endocardium of the AV canal [24]. Specifically, AV endocardial cells,
previously squamous in appearance, become more cuboidal and begin to exhibit lateral
localization of the adhesion molecule Dm-grasp. Examination of this early aspect of AV
endocardial differentiation in embryos with valve defects has demonstrated distinct roles for
the implicated pathways. In silent heart mutants, AV endocardium remains squamous and does
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not express Dm-grasp, indicating the importance of cardiac function for the initiation of
endocardial differentiation [24]. In contrast, Calcineurin signaling is not required for initial
differentiation of the AV canal endocardium, but it is important for the subsequent epithelial
to mesenchymal transformation that creates ECs [24,40]. Notch signaling, on the other hand,
seems to be responsible for the spatial restriction of AV canal differentiation [24]. In embryos
treated with the Notch pathway inhibitor DAPT, ventricular endocardium undergoes
differentiation similar to that normally observed only in the AV canal.
Characterization of cardiac cell shape changes and their subcellular patterning adds depth to
our understanding of the forces that drive cardiac morphogenesis; mutant analysis
complements this approach by bridging the gap between gene function and cellular activities.
It will be interesting to see how future studies apply cytoarchitectural analysis to other aspects
of cardiac morphogenesis, such as cardiac ballooning or the interactions of myocardial and
endocardial cells during tube assembly. Furthermore, future work will add a new point of view
of morphogenesis by employing transgenes for timelapse imaging of cardiac cell
rearrangements. Eventually, cytoarchitectural and timelapse approaches to morphogenesis are
likely to merge, once the reagents are available for monitoring the dynamics of subcellular
protein localization while morphogenesis is underway.
4. High-speed imaging: quantification of cardiac function
The embryonic zebrafish heart drives circulation through rhythmic, serial contractions of the
ventricle and atrium [10]. Cardiomyocyte contraction requires the assembly of sarcomeres,
large protein complexes that generate contractile force, and their organization into myofibrillar
arrays. Sarcomeres contract in response to cellular depolarization and remain refractory to
additional contractile cues until repolarization has occurred. Cardiomyocyte depolarization and
repolarization require the coordinated release of Ca2+, Na+, and K+ ions intracellularly and
extracellularly. Although the physiology of a mature cardiomyocyte is well characterized, less
is known about how developing cardiomyocytes acquire and coordinate their contractile
properties. How is sarcomere assembly regulated? What sets the initial embryonic heart rate?
How does the contractile pattern of the primitive heart tube transition into that of a two-
chambered organ? Zebrafish mutations causing contractility defects have the potential to
uncover the genetic pathways that control the development of cardiac function.
Numerous zebrafish mutations interfere with cardiac function, causing the heart to appear
noncontractile or poorly contractile. Several of these mutations disrupt genes encoding
components of the sarcomere, including pickwick (titin) [46], tell tale heart (cardiac myosin
light chain 2) [47], weak atrium (amhc) [13], cardiofunk (actc1) [41], and silent heart
(tnnt2) [48], and lead to problems with sarcomere assembly or maintenance. Other mutations
in this category affect genes encoding components of the electrical conduction system that
controls cardiomyocyte depolarization and repolarization. For example, the island beat
(cacna1c) locus encodes an α 1c subunit of a L-type calcium channel; island beat mutants
exhibit an abnormally shaped and noncontractile ventricle as well as atrial fibrillation,
demonstrating chamber-specific roles for this mechanism of calcium transport [49]. Like island
beat, mutation of tremblor also causes ventricular noncontractility and atrial arrhythmia; this
locus encodes a sodium/calcium exchanger, Slc8a1a, also known as Ncx1 [50,51]. The
breakdance mutation causes an arrhythmia reminiscent of that observed in human long QT
syndrome; fittingly, the breakdance gene encodes a rapidly activating, delayed rectifier K+
channel (kcnh2), defects in which are also causative for the human syndrome [52]. Analysis
of contractility mutants also suggests that endocardial-myocardial signaling may be required
to maintain contractility. Mutation of dead beat causes a progressive loss of ventricular
contractility; this locus encodes PLCγ1, a component of the vascular endothelial growth factor
(VEGF) signaling pathway [53]. Mosaic analyses demonstrate that dead beat is required cell-
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autonomously for maintenance of ventricular contractility, thereby demonstrating a previously
unappreciated role for VEGF signaling in cardiomyocytes. Manipulation of VEGF-PLCγ1
signaling in rat cardiomyocytes in culture affects their calcium cycling, suggesting a similar
function for VEGF in the embryonic heart [53].
It is easy to classify the phenotypes of contractility mutants by qualitative features, such as
noncontracility, reduced contractility, or arrhythmia. However, these categories oversimplify
the diversity of functional phenotypes, which can reflect distinctions between the roles of
specific components of the contractile apparatus or conduction system. Poor contractility, for
example, could represent a number of different problems, including defective sarcomere
assembly, ineffective sarcomere function, or reduced calcium cycling; these defects could be
present throughout the heart or only in a specific chamber or region. To distinguish between
possible roles for regulators of cardiac function, it is essential to use techniques appropriate
for the quantification of functional parameters. New high-speed imaging technologies make it
possible to resolve several useful metrics of cardiac contraction, blood flow, and cardiac
conduction.
High-speed imaging is not necessary for the measurement of certain indicators of cardiac
function in the zebrafish embryo: capturing images at normal video rate, it is straightforward
to generate simple diagnostics like heart rate and ventricular shortening [32]. However, far
more information can be extracted from high-speed analysis. Recent advancements in confocal
microscopy allow the fast and sensitive imaging of fluorescent blood cells, endocardium, and
myocardium when they are in motion; sophisticated computational tools can then reconstruct
the optical sections to create four-dimensional depictions of the beating heart [54]. These data
sets facilitate calculation of a variety of relevant metrics of cardiac function. For example,
measurement of blood cell velocities and chamber volumes has demonstrated the existence of
significant shear forces inside the heart at the stages when such forces are proposed to trigger
EC formation [42]. Reconstruction of the waves of endocardial and myocardial movement and
the patterns of blood cell displacement within the contracting heart tube have shown that the
fluid dynamics of the heart tube resemble a suction pump, challenging the notion that the heart
tube drives circulation via peristalsis (Figure 3) [55]. Examination of temporal changes in
chamber volumes, cardiac cushion movements, and patterns of blood flow have documented
the maturation of the AV valve into a functional apparatus for preventing backwards flow
[54]. This quantitative characterization of the maturation of cardiac function in wild-type
embryos provides a powerful framework for the future analysis of mutant phenotypes, although
it is important to note that analysis of irregular contractions may require refinement of
computational algorithms that are based on assumptions of the rhythmic activity expected in
wild-type embryos [54].
Tracking dynamic cell movements provides a clear readout of cardiac function; however, the
origins of functional deficiencies lie within the cells. Sarcomere status can be carefully
inspected via electron microscopy, but other techniques are necessary to monitor the cardiac
conduction system. Electrocardiograms can be used to examine cardiac voltages in the
zebrafish embryo, pacing techniques can test the electromechanical responsiveness of
embryonic hearts, and whole-cell voltage-clamp recordings of dissociated cardiomyocytes can
indicate the status of particular currents in individual cells [49]. It is also desirable to monitor
conduction in context, tracking electrical impulses in four dimensions in vivo to resolve
regional differences in conduction and changes over time. High-speed imaging of calcium
indicators allows visualization of a wave of myocardial depolarization as it progresses from
pole to pole. Application of this technique to the analysis of tremblor mutants revealed an
absence of wave-like depolarization; instead, mutant embryos exhibit high and static levels of
calcium within the ventricle and abnormal, sporadic calcium transients in the atrium [50,51].
These observations correspond well to the tremblor contractility phenotype and to the
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established role of Ncx1 in calcium extrusion. Monitoring the progress of the calcium
wavefront also makes it possible to track the maturation of cardiac conduction during the
process of chamber emergence. Combining calcium imaging and cardiac pacing, Milan et al.
have shown that AV canal myocardium acquires special characteristics around 40 hours post
fertilization (hpf), so as to slow conduction velocities between the atrium and ventricle [56].
Examination of conduction velocities in cloche mutants, which lack endocardium,
demonstrated that endocardial-myocardial signaling is necessary to induce these conductive
properties in the AV canal; in contrast, examination of silent heart mutants indicated that
cardiac contractions and blood flow are dispensable for this aspect of AV canal development.
Finally, antisense morpholino-mediated knockdown of notch1b and neuregulin, both of which
are expressed in the endocardium, inhibited deceleration of conduction at the AV junction,
implicating these genes in the functional maturation of the AV canal.
Overall, functional studies suggest a high degree of cross-species conservation of fundamental
regulatory mechanisms. Extensions of this work will undoubtedly apply high-speed imaging
techniques to the analysis of many other essential and conserved genes. Furthermore, it will
be fruitful to employ high-speed imaging to the characterization of small molecules influencing
cardiac function. Using automated microscopy, automated videography, and automated
computational analysis, Burns et al. have created a high-throughput assay that sensitively and
accurately monitors heart rate in Tg(cmlc2:gfp) embryos [57]. This strategy can be used to
rapidly screen large libraries of small molecules for their effects on contractility. The imaging
techniques described above can then be used to define the ways that particular compounds
affect contraction and conduction, potentially accelerating the pace of drug discovery.
5. Future prospects: image is everything
Taken together, recent studies of cardiac development in the zebrafish embryo emphasize the
importance of high-resolution imaging techniques for the analysis of essential regulatory
mechanisms. Rather than simply assigning a gene a role in a general process, such as
cardiomyocyte production or heart tube assembly, current techniques can reveal more
mechanistic specifics of gene function. It is possible to track fate decisions made by individual
cells, to follow subcellular localization of proteins that are integral to tissue movement and
structure, and to monitor contractile and conductive contributions to the functional output of
the organ. The next generation of experiments promise to add substantial breadth and depth to
this body of work. Of course, today’s techniques will be applied to additional interesting genes,
since there are a number of intriguing mutations in the collection that remain unexplored.
Meanwhile, many new mutations are being generated, especially using newly refined genetic
techniques, such as insertional mutagenesis and TILLING [58,59]. Furthermore, the continued
development of imaging technologies should rapidly expand the horizons of the field. For
example, it will be particularly exciting to employ new fluorescent proteins with dynamic
properties, such as the photoconvertible protein Kaede, for tracking cell movements and
rearrangements [60]. Moreover, as imaging techniques facilitate a deep understanding of
zebrafish cardiac development, it will be important to extend these studies across species to
examine the degree of conservation of the relevant developmental mechanisms. Assuming that
the fundamental aspects of the key regulatory pathways are broadly conserved, high-resolution
studies of zebrafish cardiac specification, morphogenesis, and function should shed
considerable light on the cellular and subcellular mechanisms of mammalian cardiogenesis
and the etiology of congenital heart disease.
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Figure 1.
Fate mapping reveals that atrial and ventricular cardiomyocyte organization is preconfigured
by atrial and ventricular CP organization preceding differentiation. (A–E) Images illustrating
the generation and collection of fate map data. (F–J) Schematics illustrating atrial and
ventricular CP organization. (A,B) Pseudo-colored overlay images of blastomeres (A) or
ALPM cells (B) that were labeled by laser activation of caged fluorescein, as in [21]. (A) Lateral
view, animal pole up, at 40% epiboly stage. In this example, three blastomeres in the first tier
above the embryonic margin are labeled. (B) Dorsal view, anterior up, at the 7-somite stage.
In this example, a cluster of 10–15 ALPM cells slightly interior to the ALPM edge (black
arrowhead) were labeled. (C–E) Embryos processed to score cardiac progeny of labeled cells.
Examples are at the 21-somite stage (C; dorsal view, anterior up), 30 hours post fertilization
(hpf) (D; dorsal view), and 44 hpf (E; ventral view). In situ hybridization of cmlc2 expression
[12] indicates all cardiomyocytes (magenta), and anti-fluorescein immunohistochemistry
indicates labeled progeny (blue). (F,G) Schematics depicting territories containing atrial CPs
(yellow) and ventricular CPs (red) within the LMZ (F; [21]) and the ALPM (G; J.J.S. and D.Y.,
unpublished data). (H–J) Schematics depicting the position of atrial (yellow) and ventricular
(red) cardiomyocytes within the cardiac cone (H), the heart tube (I), and the cardiac chambers
(J), as determined by expression patterns of amhc and vmhc [12,13].
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Figure 2.
Examination of cardiac cytoarchitecture demonstrates that the migrating myocardium is a
polarized epithelium. (A,B) Confocal images of transverse sections, dorsal to the top, of Tg
(cmlc2:egfp) [43] embryos at the 20-somite stage, as in [29]. Expression of Tg(cmlc2:egfp)
(pseudocolored blue) indicates bilateral populations of cardiomyocytes in the process of
cardiac fusion. Immunohistochemistry for β-catenin (red), PRKCi (green, A), and Fibronectin
(green, B) indicates protein localization. (A) At this stage, cardiomyocytes exhibit clear
apicobasal polarity, with β-catenin localized basolaterally and PRKCi localized apicolaterally.
(B) Fibronectin deposition is evident adjacent to the basal surface of the myocardial epithelia.
Images provided by L. Trinh and D. Stainier.
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Figure 3.
High-speed imaging facilitates the tracking of cardiomyocyte trajectories during cardiac
contraction. (A–D) Series of 3D renderings documenting cardiac contraction in a Tg
(cmlc2:egfp) [43] embryo at 26 hpf. The trajectories (orange tracks) of individual
cardiomyocytes (yellow balls) are indicated. Trajectory patterns vary in different regions of
the heart, indicating local distinctions in cardiomyocyte behavior during the heartbeat. As in
[55], data were acquired by A. Forouhar using a Zeiss LSM 5 LIVE fast confocal microscope
at 151 frames per second, reconstructed into 3D volumes via programs written by M. Liebling,
and rendered using Imaris (Bitplane A.G.). The arrow shows the general direction of blood
flow and is 100 microns long. Images provided by M. Liebling and M. Dickinson.
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